P Gjorstrup
Overview
Explore the profile of P Gjorstrup including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
333
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keyes K, Ye Y, Lin Y, Zhang C, Perez-Polo J, Gjorstrup P, et al.
Am J Physiol Heart Circ Physiol
. 2010 May;
299(1):H153-64.
PMID: 20435846
The purpose of the present study was to assess whether resolvin E1 (RvE1), an anti-inflammatory mediator derived from eicosapentaenoic acid, would limit myocardial infarct size in the rat. The H9c2...
2.
Lund T, Mangsbo S, Scholz H, Gjorstrup P, Totterman T, Korsgren O, et al.
Exp Clin Endocrinol Diabetes
. 2010 Feb;
118(4):237-44.
PMID: 20119897
Background: In clinical islet transplantation, inflammatory responses initiated by the transplanted islets and by the host immune system cause acute and chronic graft loss. The resolution of acute inflammation is...
3.
Whitaker J, Wolinsky J, Narayana P, Bartolucci A, Noseworthy J, Lublin F, et al.
Arch Neurol
. 2001 Feb;
58(1):49-54.
PMID: 11176936
Background: A significant correlation exists between disability and the volume of black holes (BHL VOL), defined as hypointense lesions on T1-weighted cranial magnetic resonance imaging. A consistent correlation has also...
4.
Wolinsky J, Narayana P, Noseworthy J, Lublin F, Whitaker J, Linde A, et al.
Neurology
. 2000 May;
54(9):1734-41.
PMID: 10802777
Objective: To determine the safety and efficacy of roquinimex (linomide) in the management of relapsing-remitting and secondary progressive MS as monitored by MRI. Background: Preclinical studies and several short term...
5.
Noseworthy J, Wolinsky J, Lublin F, Whitaker J, Linde A, Gjorstrup P, et al.
Neurology
. 2000 May;
54(9):1726-33.
PMID: 10802775
Objective: To determine whether linomide (roquinimex) is better than placebo in slowing the time to confirmed clinical worsening in patients with relapsing-remitting (RR) and secondary progressive (SP) MS. Methods: In...
6.
Andersen O, Lycke J, Tollesson P, Svenningsson A, Runmarker B, Linde A, et al.
Neurology
. 1996 Oct;
47(4):895-900.
PMID: 8857715
The synthetic immunomodulator Linomide, a quinoline-3-carboxamide, has a profound inhibitory influence in several experimental autoimmune diseases, including acute and chronic experimental allergic encephalomyelitis. In a double-blind trial, 31 patients with...
7.
Andersen O, Lycke J, Tollesson P, Svenningsson A, Runmarker B, Linde A, et al.
Mult Scler
. 1996 Jul;
1(6):348.
PMID: 9345415
No abstract available.
8.
9.
Palmer A, Cairns T, Dische F, Gluck G, Gjorstrup P, Parsons V, et al.
Nephrol Dial Transplant
. 1991 Jan;
6(8):536-42.
PMID: 1956551
Ten patients with rapidly progressive glomerulonephritis and acute renal failure were treated with extracorporeal immunoadsorption, prednisolone, and cyclophosphamide. Three patients had systemic lupus erythematosus, five had microscopic polyarteritis and two...
10.
Gjorstrup P, Berntorp E, Larsson L, Nilsson I
Vox Sang
. 1991 Jan;
61(4):244-50.
PMID: 1776241
Seven patients with hemophilia A and B and 3 patients with acquired hemophilia were treated on 13 and 4 occasions, respectively, with protein A immunoadsorption to reduce anti-factor VIII or...